PileUp



   MSF: 1022  Type: P  Method: vcmsa  Gopen: 0  Gext: 0

 Name: Q2I687         oo  Len:  1022  Start/End:  0,338
 Name: UBP33_HUMAN__1 oo  Len:  1022  Start/End:  0,910

//



Q2I687              MGEFWSKMAY YG........ .......... .......... .......... 
UBP33_HUMAN__1      MSAFRNHCPH LDSVGEITKE DLIQKSLGTC QDCKVQGPNL WACLENRCSY 

Q2I687              .......... .......... .......... .......... .......... 
UBP33_HUMAN__1      VGCGESQVDH STIHSQETKH YLTVNLTTLR VWCYACSKEV FLDRKLGTQP 

Q2I687              .......... .......... .......... .......LYS RSRSWSYS.. 
UBP33_HUMAN__1      SLPHVRQPHQ IQENSVQDFK IPSNTTLKTP LVAVFDDLDI EADE.E.DEL 

Q2I687              R.NYVRGLFN DSLSCCVNAL LQSFSATTEL LDILNKWN.P SDRIE.RSNI 
UBP33_HUMAN__1      RARGLTGLKN IGNTCYMNAA LQALSNCPPL TQFFLDCGGL .ARTDKKPAI 

Q2I687              PLHLKNTLLA MRDVSHP..D PHVDFLDSLY RH...TIRRY TQQDADEIFH 
UBP33_HUMAN__1      CKSYLKLMTE LWHKSRPGSV VPTTLFQGIK .TVNPTFRGY SQQDAQEFLR 

Q2I687              IILNLIQKQM PDRC...... .......... .......... .......... 
UBP33_HUMAN__1      CLMDLLHEEL KEQVMEVEED PQTITTEETM EEDKSQSDVD FQSCESCSNS 

Q2I687              .......... .......... .......... .......... .......... 
UBP33_HUMAN__1      DRAENENGSR CFSEDNNETT MLIQDDENNS EMSKDWQKEK MCNKINKVNS 

Q2I687              .......... .......... .......... .......... .......... 
UBP33_HUMAN__1      EGEFDKDRDS ISETVDLNNQ ETVKVQIHSR ASEYITDVHS NDLSTPQILP 

Q2I687              .......... .......... .......... .......... ...LAQEIRS 
UBP33_HUMAN__1      SNEGVNPRLS ASPPKSGNLW PGLAPPHKKA QSASPKRKKQ HKKYRSVISD 

Q2I687              LYEIKVETQV KCSHCASVQR MPTSLFSLPL AI........ .......... 
UBP33_HUMAN__1      IFDGTIISSV QCLTCDRVSV TLETFQDLSL PIPGKEDLAK LHSSSHPTSI 

Q2I687              .......... .......... .......... .....CEG.G NTLESCINSF 
UBP33_HUMAN__1      VKAGSCGEAY APQGWIAFFM EYVKRFVVSC VPSWFW.GPV VTLQDCLAAF 

Q2I687              FQLQNLVDGE EWFCDQCEKK QPSTHELKLV SLPPILCVHL KRFRNDRGFT 
UBP33_HUMAN__1      FARDELKGDN MYSCEKCKKL RNGVKFCKVQ NFPEILCIHL KRFRHELMFS 

Q2I687              RKLNSKVTF. LETFSTDVFA AGQSENVAND SPRAGEHYSL YAVIVHIGSA 
UBP33_HUMAN__1      TKISTHVSFP LEGLDLQPFL A...K....D SPAQIVTYDL LSVICHHGTA 

Q2I687              MSGHYTAYIR PFQDQAWYYA DDNHVQPVTW SDVQQYTYKG SSTAYLLLYR 
UBP33_HUMAN__1      SSGHYIAYCR NNLNNLWYEF DDQSVTEVSE STVQ...... NAEAYVLFYR 

Q2I687              KKSWNS.SG. .......... .......... .......... .......... 
UBP33_HUMAN__1      KSSE.EAQKE RRRISNLLNI MEPSLLQFYI SRQWLNKFKT FAEPGPISNN 

Q2I687              .......... .......... .......... .......... .......... 
UBP33_HUMAN__1      DFLCIHGGVP PRKAGYIEDL VLMLPQNIWD NLYSRYGGGP AVNHLYICHT 

Q2I687              .......... .......... .......... .......... .......... 
UBP33_HUMAN__1      CQIEAEKIEK RRKTELEIFI RLNRAFQKED SPATFYCISM QWFREWESFV 

Q2I687              .......... .......... .......... .......... .......... 
UBP33_HUMAN__1      KGKDGDPPGP IDNTKIAVTK CGNVMLRQGA DSGQISEETW NFLQSIYGGG 

Q2I687              .......... .......... ..........
UBP33_HUMAN__1      PEVILRPPVV HVDPDILQAE EKIEVETRSL

